Healy DL

No ORCID on file · 10 papers in corpus
observational 2009
Human Reproduction ·doi:10.1093/humrep/dep376

BACKGROUND: Obstetric haemorrhages have been reported to be increased after assisted reproduction technologies (ART) but the mechanisms involved are unclear. METHODS: This retrospective cohort study compared the prevalence of antepartum ha…

other 2006
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/j.1479-828x.2006.00546.x

BACKGROUND: Activin is a well-characterised growth and differentiation factor and an important inflammatory mediator. Activin is secreted by normal endometrial glands and stroma and is expressed by endometrial leucocytes. It is also known t…

review 1998
Human Reproduction Update ·doi:10.1093/humupd/4.5.736

Excessive endometrial angiogenesis is proposed as an important mechanism in the pathogenesis of endometriosis. Evidence is reviewed for the hypothesis that the endometrium of women with endometriosis has an increased capacity to proliferate…

review 1998
Annals of medicine ·doi:10.3109/07853899809002599

The possibility that ovulation induction increases the risk of ovarian cancer remains unproven. However, recent studies suggest that both infertility and endometriosis may be independent risk factors. Despite the various case reports and ep…

observational 1995
Fertility and sterility ·doi:10.1016/s0015-0282(16)57733-4

OBJECTIVE: To compare the proliferation of endothelial, epithelial, and stromal cells in the endometrium of women with endometriosis and normal controls. DESIGN: Proliferating cells were identified using the monoclonal antibody antiprolife…

review 1994
Lancet (London, England) ·doi:10.1016/s0140-6736(94)92941-6
review 1993
Bailliere's clinical obstetrics and gynaecology ·doi:10.1016/s0950-3552(05)80465-1

The management of women with endometriosis is complex and necessitates individualization of patient care. The most commonly used medical therapies are danazol, GnRH agonists, medroxyprogesterone acetate and gestrinone. Studies to date have …

nonrandomized-trial 1986
British journal of obstetrics and gynaecology ·doi:10.1111/j.1471-0528.1986.tb08652.x

LHRH agonists are synthetic peptide analogues of hypothalamic luteinizing hormone releasing hormone (LHRH) with superior potency and longer duration of gonadotrophin release. Paradoxically, repeated administration causes pituitary desensiti…

case-report 1984
British medical journal (Clinical research ed.) ·doi:10.1136/bmj.289.6454.1267
review 1983
Obstetrical & gynecological survey ·doi:10.1097/00006254-198308000-00025